Literature DB >> 29582230

Binding free energy calculations to rationalize the interactions of huprines with acetylcholinesterase.

Érica C M Nascimento1, Mónica Oliva2, Juan Andrés3.   

Abstract

In the present study, the binding free energy of a family of huprines with acetylcholinesterase (AChE) is calculated by means of the free energy perturbation method, based on hybrid quantum mechanics and molecular mechanics potentials. Binding free energy calculations and the analysis of the geometrical parameters highlight the importance of the stereochemistry of huprines in AChE inhibition. Binding isotope effects are calculated to unravel the interactions between ligands and the gorge of AChE. New chemical insights are provided to explain and rationalize the experimental results. A good correlation with the experimental data is found for a family of inhibitors with moderate differences in the enzyme affinity. The analysis of the geometrical parameters and interaction energy per residue reveals that Asp72, Glu199, and His440 contribute significantly to the network of interactions between active site residues, which stabilize the inhibitors in the gorge. It seems that a cooperative effect of the residues of the gorge determines the affinity of the enzyme for these inhibitors, where Asp72, Glu199, and His440 make a prominent contribution.

Entities:  

Keywords:  Binding free energy calculation; Binding isotope effect; Huprines; QM/MM; Stacking interactions

Mesh:

Substances:

Year:  2018        PMID: 29582230     DOI: 10.1007/s10822-018-0114-1

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  36 in total

1.  Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs.

Authors:  G Kryger; I Silman; J L Sussman
Journal:  Structure       Date:  1999-03-15       Impact factor: 5.006

2.  Huprine X and huperzine A improve cognition and regulate some neurochemical processes related with Alzheimer's disease in triple transgenic mice (3xTg-AD).

Authors:  M Ratia; L Giménez-Llort; P Camps; D Muñoz-Torrero; B Pérez; M V Clos; A Badia
Journal:  Neurodegener Dis       Date:  2012-05-24       Impact factor: 2.977

3.  Practical Aspects of Free-Energy Calculations: A Review.

Authors:  Niels Hansen; Wilfred F van Gunsteren
Journal:  J Chem Theory Comput       Date:  2014-06-06       Impact factor: 6.006

Review 4.  Calculation of protein-ligand binding affinities.

Authors:  Michael K Gilson; Huan-Xiang Zhou
Journal:  Annu Rev Biophys Biomol Struct       Date:  2007

5.  Kinetic and structural studies on the interaction of cholinesterases with the anti-Alzheimer drug rivastigmine.

Authors:  P Bar-On; C B Millard; M Harel; H Dvir; A Enz; J L Sussman; I Silman
Journal:  Biochemistry       Date:  2002-03-19       Impact factor: 3.162

6.  Interaction of a new potent anticholinesterasic compound (+/-)huprine X with muscarinic receptors in rat brain.

Authors:  S Roman; N M Vivas; A Badia; M V Clos
Journal:  Neurosci Lett       Date:  2002-06-07       Impact factor: 3.046

7.  Structure of acetylcholinesterase complexed with (-)-galanthamine at 2.3 A resolution.

Authors:  H M Greenblatt; G Kryger; T Lewis; I Silman; J L Sussman
Journal:  FEBS Lett       Date:  1999-12-17       Impact factor: 4.124

8.  Predicting relative binding free energies of tacrine-huperzine A hybrids as inhibitors of acetylcholinesterase.

Authors:  X Barril; M Orozco; F J Luque
Journal:  J Med Chem       Date:  1999-12-16       Impact factor: 7.446

9.  Potentiation effects of (+/-)huprine X, a new acetylcholinesterase inhibitor, on nicotinic receptors in rat cortical synaptosomes.

Authors:  S Roman; A Badia; P Camps; M V Clos
Journal:  Neuropharmacology       Date:  2004-01       Impact factor: 5.250

10.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility.

Authors:  Garrett M Morris; Ruth Huey; William Lindstrom; Michel F Sanner; Richard K Belew; David S Goodsell; Arthur J Olson
Journal:  J Comput Chem       Date:  2009-12       Impact factor: 3.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.